Ventilator-associated tracheobronchitis increases the length of intensive care unit stay

Infection Control and Hospital Epidemiology

Volumn 34, Issue 8, 2013, Pages 800-808

  Karvouniaris, Marios ^a   Makris, Demosthenes ^a   Manoulakas, Efstratios ^a   Zygoulis, Paris ^a   Mantzarlis, Konstantinos ^a   Triantaris, Apostolos ^a   Chatzi, Maria ^a   Zakynthinos, Epaminondas ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATE; BRONCHIAL ASPIRATION PROCEDURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK FACTOR; THORAX RADIOGRAPHY; TRACHEOBRONCHITIS; VENTILATOR ASSOCIATED PNEUMONIA; VENTILATOR ASSOCIATED TRACHEOBRONCHITIS;

ADULT; AGE FACTORS; AGED; APACHE; BRONCHITIS; C-REACTIVE PROTEIN; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK FACTORS; TRACHEITIS; VENTILATORS, MECHANICAL;

EID: 84880066646     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/671274     Document Type: Article

References (37)

1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
2. Rello J, Ollendorf DA, Oster G, et al; VAP Outcomes Scientific Advisory Group. Epidemiology and outcomes of ventilatorassociated pneumonia in a large US database. Chest 2002;122: 2115-2121.
3. Bercault N, Boulain T. Mortality rate attributable to ventilatorassociated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001;29: 2303-2309.
4. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:1312-1317.
5. Heyland DK, Cook DJ, Griffin L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999;159:1249-1256.
6. Nseir S, Di Pompeo C, Pronnier P, et al. Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J 2002;20:1483-1489.
7. Agrafiotis M, Siempos II, Falagas ME. Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: systematic review and meta-analysis. Respir Med 2010; 104:325-336.
8. Craven DE, Chroneou A, Zias N, Hjalmarson KI. Ventilatorassociated tracheobronchitis (VAT): the impact of targeted antibiotic therapy on patient outcomes. Chest 2008;135:521-528.
9. Palmer LB Ventilator-associated infection. Curr Opin Pulm Med 2009;15:230-235.
10. Nseir S, Di Pompeo C, Soubrier S, et al. Effect of ventilatorassociated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control study. Crit Care 2005; 9:R238-R245.
11. Nseir S, Favory R, Jozefowicz E, et al; VAT Study Group. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized controlled multicenter study. Crit Care 2008; 12:R62.
12. Palmer LB, Smaldone GC, Chen JJ, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008;36:2008-2013.
13. Dallas J, Skrupky Lee, Abebe N, Boyle WA 3rd, Kollef MH. Ventilator-associated tracheobronchitis in a mixed surgical and medical ICU population. Chest 2011;139:513-518.
14. Craven DE, Hjalmarson KI. Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box. Clin Infect Dis 2010;51(S1):S59-S66.
15. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005: 171:388-416.
16. Torres A, Valencia M. Does ventilator-associated tracheobronchitis need antibiotic treatment? Crit Care 2005;9:255-256.
17. Wunderink RG. Ventilator-associated tracheobronchitis: publicreporting scam or important clinical infection? Chest 2011;139: 485-488.
18. WHONET Greece. Cumulative results of January-June 2010. http://www.mednet.gr/whonet. Accessed July 21, 2012.
19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit CareMed 1985; 13:818-829.
20. Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicentric, prospective study. Crit Care Med 1998;26:1793-1800.
21. Cohen J. Weighed kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychological Bulletin 1968; 70(4):213-220.
22. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505-511.
23. Rea-Neto A, Youssef NCM, Tuche F, et al. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care 2008;12:R56.
24. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheterrelated infection: 2009 update by the Infectious Disease Society of America. Clin Infect Dis 2009;49:1-45.
25. Institute for Healthcare Improvement. Bundle up for safety. http://www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare /Changes/ImplementtheVentilatorBundle.htm. Accessed March 10, 2009.
26. Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med 2007;101:1305-1312.
27. Rodríguez-Baño J, Millán AB, Domínguez MA, et al; GEIH/ GEMARA/REIPI. Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus. J Infect 2009;58:131-137.
28. Bouderka MA, Fakhir B, Bouaggad A, Hmamouchi B, Hamoudi D, Harti A. Early tracheostomy versus prolonged endotracheal intubation in severe head injury. J Trauma 2004;57:251-254.
29. Lambert M-L, Suetens C, Savey A, et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011;11:30-38.
30. Grundmann H, Livermore DM, Giske CG, et al; CNSEWorking Group. Carbapenem-non-susceptible enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill 2010;15(46):pii19711.
31. Ho J, Tambyah PA, Paterson DL. Multiresistant gram-negative infections: a global perspective. Curr Opin Infect Dis 2010;23: 546-553.
32. Hayon J, Figliolini C, Combes A, et al. Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:41-46.
33. Depuydt P, Benoit D, Vogelaers D, et al. Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia. Intensive Care Med 2008;34:675-682.
34. Michel F, Franceschini B, Berger P, et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 2005;127: 589-597.
35. Schetz MR, Van den Berghe G. Do we have reliable biochemical markers to predict the outcome of critical illness? Int J Artif Organs 2005;28:1197-1210.
36. Gartman EJ, Casserly BP, Martin D, Ward NS. Using serial severity scores to predict death in ICU patients: a validation study and review of the literature. Curr Opin Crit Care 2009;15:578-582.
37. Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review. Crit Care 2008;12(6):R161.